Amdocs Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs or view top-rated stocks.

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Amdocs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) issued its earnings results on Tuesday, August, 3rd. The technology company reported $1.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.17. The technology company earned $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Amdocs had a trailing twelve-month return on equity of 15.98% and a net margin of 16.44%. The company's revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company posted $1.07 earnings per share.
View Amdocs' earnings history.

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DOX shares have increased by 24.1% and is now trading at $76.23.
View which stocks have been most impacted by COVID-19.

Amdocs declared a quarterly dividend on Wednesday, August 4th. Investors of record on Thursday, September 30th will be given a dividend of $0.36 per share on Friday, October 29th. This represents a $1.44 annualized dividend and a yield of 1.89%. The ex-dividend date of this dividend is Wednesday, September 29th.
View Amdocs' dividend history.

Amdocs pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.90%. Amdocs has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 34.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 29.09% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

Amdocs issued an update on its fourth quarter 2021 earnings guidance on Wednesday, August, 25th. The company provided earnings per share guidance of $1.130-$1.190 for the period, compared to the Thomson Reuters consensus estimate of $1.280. The company issued revenue guidance of $1.07 billion-$1.11 billion, compared to the consensus revenue estimate of $1.09 billion.

2 brokerages have issued 12-month price targets for Amdocs' shares. Their forecasts range from $75.00 to $99.00. On average, they anticipate Amdocs' stock price to reach $87.00 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts' price targets for Amdocs or view top-rated stocks among Wall Street analysts.

915 employees have rated Amdocs CEO Shuky Sheffer on Glassdoor.com. Shuky Sheffer has an approval rating of 90% among Amdocs' employees.

Some companies that are related to Amdocs include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Gartner (IT), Leidos (LDOS), Booz Allen Hamilton (BAH), CACI International (CACI), Teradata (TDC), ManTech International (MANT), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of DOX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (12.50%), Massachusetts Financial Services Co. MA (4.93%), Wells Fargo & Company MN (4.18%), Pzena Investment Management LLC (4.01%), LSV Asset Management (3.80%) and BlackRock Inc. (3.11%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Cooke & Bieler LP, Morgan Stanley, Morgan Stanley, Prudential Financial Inc., Cubist Systematic Strategies LLC, Goldman Sachs Group Inc., and AQR Capital Management LLC.

DOX stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Massachusetts Financial Services Co. MA, American Century Companies Inc., Pzena Investment Management LLC, Panagora Asset Management Inc., Millennium Management LLC, Bank of Montreal Can, and Marshall Wace North America L.P..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOX stock can currently be purchased for approximately $76.23.

Amdocs has a market capitalization of $9.99 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis.

Amdocs employs 25,875 workers across the globe.

The following companies are subsidiares of Amdocs: AMDOCS (AUSTRALIA) PTY LTD, AMDOCS (CR) s.r.o., AMDOCS (ITALY) SRL, AMDOCS (PORTUGAL) SOFTWARE UNIPESSOAL LDA, AMDOCS (UK) LIMITED, AMDOCS ASTRUM LIMITED, AMDOCS BRASIL LTDA, AMDOCS BULGARIA EOOD, AMDOCS DEVELOPMENT CENTRE INDIA LLP, AMDOCS DEVELOPMENT LIMITED, AMDOCS ECUADOR S.A., AMDOCS FRANCE, AMDOCS HELLAS LTD, AMDOCS HONG KONG LIMITED, AMDOCS INVESTMENTS SWITZERLAND LIMITED, AMDOCS MANAGEMENT LIMITED, AMDOCS MONTENEGRO D.O.O., AMDOCS PERU S.A.C., AMDOCS PHILIPPINES INC., AMDOCS SINGAPORE PTE. LTD., AMDOCS SOFTWARE GmbH, AMDOCS SPAIN SLU, AMDOCS SYSTEMS EUROPE LIMITED, AMDOCS SYSTEMS GROUP LIMITED, AMDOCS SYSTEMS LIMITED, AMDOCS TETHYS LIMITED, AMDOCS VIETNAM COMPANY LIMITED, AMDOCS YAZILIM HIZMETLERI ANONIM SIRKETI, Actix, Amdocs (Finland) Oy, Amdocs Advertising And Media - Emea ApS, Amdocs B.V., Amdocs Canadian Managed Services Inc, Amdocs Champaign Inc., Amdocs Chile SpA, Amdocs Costa Rica SR Ltda, Amdocs Inc., Amdocs International GmbH, Amdocs México S. de R.L. de C.V., Amdocs Qpass Inc., Amdocs Software Megoldások Korlátolt Felelosségu Társaság, Amdocs Software Services Américas S. de R.L. de C.V., Amdocs Software Technologies Inc, Amdocs Systems AB, BRITE:BILL GROUP LIMITED, Bridgewater Systems, Brite:Bill, CRAMER LIMITED, Celcite, Changingworlds, Cramer Systems, DST Innovis, ECHOS SERVICOS SA, EUROPEAN SOFTWARE MARKETING LTD, EUROPEAN SUPPORT LIMITED, Hungarian Innovation Systems Korlátolt Felelosségu Társaság, IGNIS UK INVESTMENT LIMITED, INVENTIS DEVELOPMENTS LIMITED, Jacobs Rimell Ltd., MX Telecom, OPENMARKET LIMITED, OPENMARKET PTY LTD, ORBIS INVESTMENT LTD, Openet, Openmarket Inc., Opis Investment Switzerland GmbH, PT. AMDOCS INDONESIA, PT. APPLICATION SOLUTIONS, PT. SOFTWARE SOLUTIONS INDONESIA, Pontis, Projekt202 LLC, Qpass, Solect Technology Group, Sourced Group, Streamezzo, Telecom Technology Services, UNIVERSUM INVESTMENTS LTD, UTIBA PTE LTD, UTIBA SOFTWARE SOLUTIONS (SINGAPORE) PTE. LTD., UXP Systems GmbH, UXP Systems Inc, Vindicia, Vubiquity, XACCT Technologies, cVidya, and jNetX.

Amdocs was founded in 1982.

The official website for Amdocs is www.amdocs.com.

Amdocs is headquartered at 1390 Timberlake Manor Parkway, Chesterfield MO, 63017.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at (314) 212-7000 or via email at [email protected].